Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cvitkovic

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Annals of Neurology|November 1, 1977
"Disappearing" spinal cord compression: oncolytic effect of glucocorticoids (and other chemotherapeutic agents) on epidural metastasesJ B Posner, J Howieson, E Cvitkovic
Hematology/Oncology Clinics of North America|August 1, 1991
Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implicationsE Cvitkovic, M Bachouchi, J P Armand
Clinical Toxicology|January 1, 1978
cis-Platinum ototoxicityL Helson, E Okonkwo, L Anton, et al.
Chest|February 1, 1979
Spontaneous pneumothorax as a result of intensive cytotoxic chemotherapyP Schulman, E Cheng, E Cvitkovic, et al.
Seminars in Oncology|June 3, 1998
Oxaliplatin for the treatment of advanced colorectal cancer: future directionsM Ducreux, C Louvet, M Bekradda, et al.
Advances in Experimental Medicine and Biology|January 1, 1975
Studies on the sensitivity of anticancer agents of normal human cells in cultureL Morasca, G Balconi, E Erba, et al.
Cancer Treatment Reports|September 1, 1979
cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lungR J Gralla, E Cvitkovic, R B Golbey
Bulletin Du Cancer|June 1, 1997
[Oxaliplatin: the first DACH platinum in clinical practice]P Soulié, E Raymond, S Brienza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatinN Zeghari-Squalli, E Raymond, E Cvitkovic, et al.
Cancer Chemotherapy and Pharmacology|July 21, 1999
Supraadditive effect of 2',2'-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell linesS Faivre, E Raymond, J M Woynarowski, et al.
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Annals of Neurology|November 1, 1977
"Disappearing" spinal cord compression: oncolytic effect of glucocorticoids (and other chemotherapeutic agents) on epidural metastasesJ B Posner, J Howieson, E Cvitkovic
Hematology/Oncology Clinics of North America|August 1, 1991
Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implicationsE Cvitkovic, M Bachouchi, J P Armand
Clinical Toxicology|January 1, 1978
cis-Platinum ototoxicityL Helson, E Okonkwo, L Anton, et al.
Chest|February 1, 1979
Spontaneous pneumothorax as a result of intensive cytotoxic chemotherapyP Schulman, E Cheng, E Cvitkovic, et al.
Seminars in Oncology|June 3, 1998
Oxaliplatin for the treatment of advanced colorectal cancer: future directionsM Ducreux, C Louvet, M Bekradda, et al.
Advances in Experimental Medicine and Biology|January 1, 1975
Studies on the sensitivity of anticancer agents of normal human cells in cultureL Morasca, G Balconi, E Erba, et al.
Cancer Treatment Reports|September 1, 1979
cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lungR J Gralla, E Cvitkovic, R B Golbey
Bulletin Du Cancer|June 1, 1997
[Oxaliplatin: the first DACH platinum in clinical practice]P Soulié, E Raymond, S Brienza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatinN Zeghari-Squalli, E Raymond, E Cvitkovic, et al.
Cancer Chemotherapy and Pharmacology|July 21, 1999
Supraadditive effect of 2',2'-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell linesS Faivre, E Raymond, J M Woynarowski, et al.
Pageof 13